HIGHLIGHTS
- who: Xuewei Li from the University, Weifang, Shandong, China have published the research work: 1,25-dihydroxyvitamin D3 ameliorates lupus nephritis through inhibiting the NF-κB and MAPK signalling pathways in MRL/lpr mice, in the Journal: (JOURNAL)
- what: The authors investigated the time-dependent effects of 1 and explored the underlying mechanism in a well-studied animal model of LN. The study showed that 1,25-dihydroxyvitamin D3 treatment ameliorates lupus nephritis in MRL/lpr mice, as shown by improved renal function, decreased immune complex deposition, reduced inflammatory cytokine production, and diminished NF-κB . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.